serum pepsinogen (PG) tests correlate with the occurrence of gastric atrophy and intestinal metaplasia. However, because of its low sensitivity, Huang et al report that in North America, where Helicobacter pylori prevalence is low (8%) and the use of proton pump inhibitors is frequent, the discrimination value for gastric preneoplastic lesions, atrophic gastritis, and intestinal metaplasia of gastropanel biomarkers is too low to obtain good results.
Biomarkers and OLGIM Stage for Prospective Preneoplastic Risk Stratification
Cannizzaro R.Conceptualization
2021-01-01
Abstract
serum pepsinogen (PG) tests correlate with the occurrence of gastric atrophy and intestinal metaplasia. However, because of its low sensitivity, Huang et al report that in North America, where Helicobacter pylori prevalence is low (8%) and the use of proton pump inhibitors is frequent, the discrimination value for gastric preneoplastic lesions, atrophic gastritis, and intestinal metaplasia of gastropanel biomarkers is too low to obtain good results.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
bioamrkers e olgim.pdf
Accesso chiuso
Tipologia:
Documento in Versione Editoriale
Licenza:
Copyright Editore
Dimensione
121.6 kB
Formato
Adobe PDF
|
121.6 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
bioamrkers+e+olgim-Post_print.pdf
Open Access dal 10/02/2022
Tipologia:
Bozza finale post-referaggio (post-print)
Licenza:
Creative commons
Dimensione
680.8 kB
Formato
Adobe PDF
|
680.8 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
